You are here
- Home
Total number of clinical trials
- collapse A Phase I, Single Centre, Double-blind, Randomised, Placebo-controlled, Parallel-group Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Inhaled AZD8683 After Single Ascending Doses Administered Via Turbuhaler in Healthy Subjects
- collapse A Phase II, Open Label, Non-Randomized Study of [18F]AZD4694 to Compare PET Measurements of Fibrillar Amyloid Burden Obtained Using Difference Scanning Parameters, Reference Region Procedures and to Assess Test-retest Reliability in Patients with AD & HV
- collapse An Open-label, Single-center Study to Assess the Pharmacokinetics of NKTR-118 in Patients with Impaired Hepatic Function and Subjects with Normal Hepatic Function Following Administration of a Single Dose of 25mg NKTR-118
- collapse The Tolerability and Effects of AZD8848 in Allergic Asthma Subjects Challenged With Inhaled Allergen
- collapse Investigating safety, tolerability and pk when giving single and fractionated doses of AZD3241 to healthy volunteers
- collapse An Open-Label, Parallel-Group, Phase I Study to Compare the Pharmacokinetics of NKTR-118 Following a Single Oral Dose in Subjects with Renal Impairment and Subjects with Normal Renal Function
- collapse A phase I, multi-centre, double-blind, placebo-controlled parallel group study to assess the pharmacoMRI effects of AZD6765 in male and female patients fulfilling the criteria for major depressive disorder
- collapse A Phase I, Randomized, Double-Blind, Four-way Cross-over Study in Healthy Subjects to Assess Quantitative Electroencephalography (qEEG) Parameters After the Administration of Ketamine, Two Doses of AZD6765 and Placebo
- collapse A Pharmacoepidemiological Study to Examine Patient Characteristics, Drug Utilization Pattern and Crude Incidence Rates of Selected Outcomes in New Users of Ticagrelor, Clopidogrel and Prasugrel in The Health Improvement Network (THIN) Database in the United Kingdom (UK).
- collapse An Open-Label, Single Center An Open, Partly Randomised, Four-way Cross-over Study in Healthy Subjects and in Patients with Mild Allergic Asthma to Investigate the Bioavailability and Basic Pharmacokinetics of a Single Dose of AZD5423 when Administered Intravenously, Orally, Inhaled via SPIRA Nebuliser or Inhaled via I-neb® AAD Systems
